EGOTUX® CAPS 12.5MG/CAP Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

egotux® caps 12.5mg/cap

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 12.5mg/cap - sunitinib 12,5mg - sunitinib

EGOTUX® CAPS 25MG/CAP Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

egotux® caps 25mg/cap

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - sunitinib 25mg - sunitinib

EGOTUX® CAPS 37.5MG/CAP Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

egotux® caps 37.5mg/cap

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 37.5mg/cap - sunitinib 37,5mg - sunitinib

EGOTUX® CAPS 50MG/CAP Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

egotux® caps 50mg/cap

genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50mg/cap - sunitinib 50mg - sunitinib

ORGARAN INJ.SOL 750 Anti-Xa Factor Units/0,6ml AMP Yunani - Yunani - Εθνικός Οργανισμός Φαρμάκων

orgaran inj.sol 750 anti-xa factor units/0,6ml amp

mylan ire healthcare limited, ireland unit 35/36 grange parade, - dublin 13 - danaparoid sodium - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 750 anti-xa factor units/0,6ml amp - danaparoid sodium 1.250xa - danaparoid

Sutent Uni Eropa - Yunani - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Αντινεοπλασματικοί παράγοντες - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

INFLUVAC SUB-UNIT SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

influvac sub-unit suspension for injection in pre-filled syringe

mylan ire healthcare limited (0000010616) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215); a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224); b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection in pre-filled syringe - a/victoria/2570/2019 (h1n1)pdm09-like strain (a/victoria/2570/2019, ivr-215) (8000004843) 15ug; a/cambodia/e0826360/2020 (h3n2)-like strain (a/cambodia/e0826360/2020, ivr- 224) (8000004845) 15ug; b/washington/02/2019-like strain (b/washington/02/2019, wild type) (8000004816) 15ug - influenza, purified antigen

SUTIREM 12.5MG CAPSULE,HARD Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sutirem 12.5mg capsule,hard

remedica ltd (0000003171) aharnon str., lemesos, 3056 - sunitinib - capsule,hard - 12.5mg - sunitinib (8000003189) 12,5mg

SUTIREM 37.5MG CAPSULE,HARD Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sutirem 37.5mg capsule,hard

remedica ltd (0000003171) aharnon str., lemesos, 3056 - sunitinib - capsule,hard - 37.5mg - sunitinib (8000003189) 37,5mg

SUTIREM 25MG CAPSULE,HARD Siprus - Yunani - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sutirem 25mg capsule,hard

remedica ltd (0000003171) aharnon str., lemesos, 3056 - sunitinib - capsule,hard - 25mg - sunitinib (8000003189) 25mg